# GLP-1s: Real-world insights from 10,000 users

The obesity treatment landscape is evolving rapidly with the proliferation of GLP-1s, but traditional real-world data (RWD) sources lack context, completeness, and the ability to track patient experiences over time. This webinar explores how Evidation’s direct-to-individual approach to collecting RWD—engaging people before they become patients—is unlocking new insights that can transform patient understanding.

Learn how Evidation is using an established, direct connection to 5 million people to:

- Capture real-world weight management journeys, including GLP-1 usage, adherence, and discontinuation trends.
- Leverage wearable data for continuous tracking of weight, heart health, activity, and sleep.
- Integrate multi-modal data (including genetic and EHR data) to generate longitudinal insights that can power predictive modeling and early interventions.

Download a copy of the presentation slides [**here**](https://8187466.fs1.hubspotusercontent-na1.net/hubfs/8187466/Evidation%20Webinar_GLP1%20Insights_25Feb2025_Final.pdf) **.**

Watch the webinar [**here**](https://www.fiercepharma.com/premium/webinar/1368068?pk=Evidation-Webpage).

## Related Therapeutic Areas:

[Obesity](/content/therapeutic-area/obesity/index.html)

[Metabolic & Endocrine](/content/therapeutic-area/metabolic-endocrine/index.html)